Skip to main content
ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS · Real-Time Price · USD
4.380
-0.020 (-0.45%)
Dec 20, 2024, 4:00 PM EST - Market closed

ReShape Lifesciences Revenue

ReShape Lifesciences had revenue of $2.29M in the quarter ending September 30, 2024, with 6.36% growth. This brings the company's revenue in the last twelve months to $8.18M, down -16.55% year-over-year. In the year 2023, ReShape Lifesciences had annual revenue of $8.68M, down -22.79%.

Revenue (ttm)
$8.18M
Revenue Growth
-16.55%
P/S Ratio
0.22
Revenue / Employee
$282,172
Employees
29
Market Cap
3.12M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.68M-2.56M-22.79%
Dec 31, 202211.24M-2.36M-17.35%
Dec 31, 202113.60M2.30M20.36%
Dec 31, 202011.30M-3.79M-25.12%
Dec 31, 201915.09M14.48M2,385.83%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InMed Pharmaceuticals 4.96M
Lipella Pharmaceuticals 483.53K
Azitra 97.50K
Alaunos Therapeutics 7.00K
Titan Pharmaceuticals 3.00K
Revenue Rankings

RSLS News

More News